Identification of Potential SARS-CoV-2 Main Protease (MPro) Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Approaches
Open Access
- 27 August 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7684
Abstract
The main protease (MPro) of coronaviruses (CoVs) is an essential enzyme involved in viral replication and represents an attractive target for antiviral drug discovery. Based on the similar binding pocket residues within the MPro of different CoVs, this study aimed to identify potential inhibitors of SARS-CoV-2 MPro from PDB ID 6M2N using integrated computational approaches. Interaction-based pharmacophore modeling, virtual screening, molecular docking, MM-GBSA binding energy calculation, and molecular dynamics simulation (MDS) were performed using BIOVIA Discovery Studio. The validated pharmacophore model was utilized to screen the ZINC database, followed by docking and 100 ns MDS analyses of the top-ranked compounds. The pharmacophore model 01 demonstrated favorable predictive performance (AUC = 0.781). Virtual screening identified 483 compounds, from which 15 compounds were selected for docking studies. Among them, ZINC95473654 (Lig-1), ZINC95473725 (Lig-2), and ZINC08792368 (Lig-3) exhibited strong binding affinity toward MPro. Lig-1 demonstrated the best docking score and binding free energy, along with stable interactions with key catalytic residues HIS41, CYS145, and GLU166. MDS analyses further confirmed that Lig-1, Lig-2 and Lig-3 maintained stable conformations. The hydrogen bond distance monitoring and post MDS-MM-GBSA results suggest Lig-1 followed by Lig-3 as an inhibitor for MPro and persistent intermolecular interactions throughout the 100 ns simulation period. The findings suggest that Lig-1, followed by Lig-3, may serve as promising computational lead compounds targeting SARS-CoV-2 MPro, representing promising candidates for further experimental validation.Keywords
All Related Versions
Funding Information
- U.S. Department of Agriculture (NI26AHDRXXXXG063-0001)
- Long Island University (40262)
This publication has 72 references indexed in Scilit:
- A Structure‐Based Design Strategy with Pyrazole‐Pyridine Derivatives Targeting TNFα as Anti‐Inflammatory Agents: E‐Pharmacophore, Dynamic Simulation, Synthesis and In Vitro EvaluationChemistry & Biodiversity, 2024
- Identification of potential oral cancer drugs as Bcl-2 inhibitors from known anti-neoplastic agents through docking studiesJournal of Mathematical Chemistry, 2023
- Structural differences in 3C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: molecular insights revealed by Molecular Dynamics SimulationsStructural Chemistry, 2022
- Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity predictionStructural Chemistry, 2022
- Betaretrovirus infections in dromedary camels in Saudi ArabiaVeterinary Medicine and Science, 2022
- The next‐generation coronavirus diagnostic techniques with particular emphasis on the SARS‐CoV‐2Journal of Medical Virology, 2021
- A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors**ChemMedChem, 2020
- The SARS-CoV-2 main protease as drug targetBioorganic & Medicinal Chemistry Letters, 2020
- Comparative analysis of the genome structure and organization of the Middle East respiratory syndrome coronavirus (MERS‐CoV) 2012 to 2019 revealing evidence for virus strain barcoding, zoonotic transmission, and selection pressureReviews in Medical Virology, 2020
- Molecular characterization and phylogenetic analyses of virulent infectious bronchitis viruses isolated from chickens in Eastern Saudi ArabiaVirusDisease, 2017